Study design and rationale of the TXL-CAP trial: a randomized, double-blind, placebo-controlled, multicenter clinical trial assessing the effect of Tongxinluo capsules on the stability of coronary atherosclerotic plaques.
- DOI
- 10.26599/1671-5411.2025.07.004
- Published
- 2025 Jul 28
- Container
- Journal of geriatric cardiology : JGC
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.26599/1671-5411.2025.07.004,
title = {Study design and rationale of the TXL-CAP trial: a randomized, double-blind, placebo-controlled, multicenter clinical trial assessing the effect of Tongxinluo capsules on the stability of coronary atherosclerotic plaques.},
author = {Ni M and Ti Y and Qi Y and Zhang M and Duan DD and Yao C and Jia ZH and Zhang Y and Bu PL},
year = {2025},
journal = {Journal of geriatric cardiology : JGC},
doi = {10.26599/1671-5411.2025.07.004},
url = {https://doi.org/10.26599/1671-5411.2025.07.004}
}RIS
TY - JOUR TI - Study design and rationale of the TXL-CAP trial: a randomized, double-blind, placebo-controlled, multicenter clinical trial assessing the effect of Tongxinluo capsules on the stability of coronary atherosclerotic plaques. AU - Ni M AU - Ti Y AU - Qi Y AU - Zhang M AU - Duan DD AU - Yao C AU - Jia ZH AU - Zhang Y AU - Bu PL PY - 2025 JO - Journal of geriatric cardiology : JGC DO - 10.26599/1671-5411.2025.07.004 UR - https://doi.org/10.26599/1671-5411.2025.07.004 ER -
APA
M, N., Y, T., Y, Q., M, Z., DD, D., C, Y., ZH, J., Y, Z., & PL, B. (2025). Study design and rationale of the TXL-CAP trial: a randomized, double-blind, placebo-controlled, multicenter clinical trial assessing the effect of Tongxinluo capsules on the stability of coronary atherosclerotic plaques.. Journal of geriatric cardiology : JGC. https://doi.org/10.26599/1671-5411.2025.07.004
Source records
- pubmed · retrieved 2026-09-27T07:33:03.370Z